Industrial and Regulatory Implementation of Non-Animal Integrated Testing Strategies
Progress in skin sensitization and lessons learnt from other areas
June 10, 2014, 10.00h - 12.30h,
Egmond aan Zee, The Netherlands
This pre-congress workshop is held in combination with the ESTIV 2014 meeting, which takes place from June 10-13
On June 10 in the evening, an IVTIP business diner for IVTIP members only takes place near Egmond aan Zee
This part of the website is for IVTIP members and observers who have participated in IVTIP meetings.
Access is only possible with a username and password, provided by the
IVTIP Secretariat.
This part of the website is for non-IVTIP members who have attended IVTIP meetings as participant.
Access is only possible with a username and password as provided by the IVTIP Secretariat.
IVTIP members represent test developers, CROs(1), SMEs(2) and large companies (sectors: chemicals, cosmetics, consumer products and pharmaceuticals).
(1): contract research organizations; (2): small and medium sized enterprises.
Our members are genuinely interested in the use of in vitro testing for regulatory/safety testing or early decision-making in compound discovery and development. IVTIP members endorse “The 21st Century Toxicity Testing’’ strategy as the ultimate replacement of animal experimentation for regulatory/safety testing.
IVTIP promotes the implementation and acceptance of replacement strategies by industry and regulatory authorities through specific key activities:
(i) informing members about existing and approaching programmes, regulations
and directives concerning animal experimentation and 3Rs strategies;
(ii) informing the relevant institutions of the European Commission of industrial experiences with current initiatives and guidelines, and the needs within industry for replacement strategies;
(iii) assuring dissemination of progress and knowledge, and transfer of state-of-the-art technology with industrial applicability to IVTIP members;
(iv) representing the members at relevant organisationsin e.g. ECVAM(3), ESTAF(4) and EPAA(5) for driving the implementation and acceptance of 3Rs approaches for regulatory/safety testing.
(3) European Center for Validation (ECVAM), (4) ECVAM Stakeholder Forum, (5) European Partnership for Alternative Approaches to Animal Experimentation
Companies sharing our interests are invited to apply for membership. The annual membership fee is € 907,50 for small enterprises, € 1.815 for medium-sized enterprises and € 3.630 for large enterprises.
IVTIP organizes annually two meetings covering issues selected by the IVTIP members. These informal discussion forums enable ample opportunity to network, discuss and ask questions.
Given the diversity among the members, general and specific expertise and guidance can be sought and found from various scientific angles opening up possibilities for new opportunities.
IVTIP meetings are dedicated to concerns of IVTIP members. These concerns are discussed and the collective IVTIP viewpoint is presented by IVTIP representatives to relevant institutions of the European Commission (e.g. ECVAM, ESTAF, EPAA) and regulatory authorities.
IVTIP regularly publishes peer-reviewed papers expressing the opinion of the IVTIP members about selected topics.
The IVTIP website allows you to promote new developments in the area of in vitro testing.
The IVTIP website gives you access to relevant information and links. Minutes, presentations and posters of past meetings can be downloaded from the Secure Area of this website. The Secure Area is divided into a part for members only and a part for non-members who participated in IVTIP meetings.